Skip to main content

Biotech’s Next Wave May Already be in Motion

Insider Bets on what may become a Brain Cancer Moonshot DENVER, May 07, 2026 (GLOBE NEWSWIRE) — (www.247marketnews.com and NeOnc Technology) – The biotech and pharma sector is entering one of its most pivotal periods in years, where insider conviction, late-stage clinical wins, and platform technologies are converging to reshape both valuations and patient outcomes. From aggressive insider buying ahead of critical data to blockbuster Phase 3 readouts redefining entire therapeutic categories, the market is signaling that the next cycle of winners may already be taking shape. At the center of this narrative sits a lesser-known but increasingly watched name: NeOnc Technologies (NASDAQ:NTHI), a company whose leadership is making a bold, highly visible bet ahead of imminent clinical data. NeOnc Technologies: Insider Conviction...

Continue reading

Primech Holdings Secures Approximately US$24.8 Million Four-Year Contract at a Major Asian Aviation Hub, Adding Significant Recurring Revenue Visibility

Award Reinforces Primech’s Position as a Trusted Partner for Mission-Critical, High-Traffic Facility Environments While Strengthening Long-Term Revenue Predictability SINGAPORE, May 07, 2026 (GLOBE NEWSWIRE) — Primech Holdings Limited (Nasdaq: PMEC) (“Primech” or the “Company”), an established technology-driven facility solutions service provider serving public and private sectors across Singapore, today announced that its wholly owned subsidiary, Primech A & P Pte. Ltd. (“Primech A & P”), has been awarded a four-year cleaning services contract with an estimated value of approximately US$24.8 million. The contract was awarded by one of Asia’s largest aviation hubs and covers routine and periodic cleaning services across multiple levels of a high-volume passenger terminal. The award represents one of the most significant...

Continue reading

Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026

20+ presentations highlight expanding role in pediatric lung disease, treatment-response assessment, and pharma trial endpointsXenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026Xenon MRI continues to evolve into a practical cardiopulmonary biomarker platform for clinical trials and therapeutic developmentDURHAM, NC and LONDON, May 07, 2026 (GLOBE NEWSWIRE) — Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, will be featured at the American Thoracic Society’s (ATS) 2026 Respiratory Innovation Summit (RIS), taking place May 15–16 in Orlando, Florida. Polarean will also participate in the ATS 2026 International Conference from May 17–20, engaging with leaders across pulmonary medicine, research, and drug development. The Company’s presence across both RIS and...

Continue reading

Inter&Co Delivers Record First Quarter, Surpassing 44 Million Clients and R$50 Billion (US$9.5B) in Credit as AI-Powered Super App Strategy Accelerates

MIAMI, May 07, 2026 (GLOBE NEWSWIRE) — Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), the leading super app providing financial and digital commerce services to over 44 million customers, today reported its results for the first quarter of 2026. 1Q26 Highlights: Inter delivered another quarter of exceptional growth across key metrics, maintaining its consistent profitability trajectory and demonstrating the strength of its complete ecosystem and Inter by Design model.Client Growth: Reached 44 million total clients, achieving the highest quarterly jump in activation rate since 2024, nearly 60%, reflecting deep and growing client engagement. Net Income: Achieved R$395 million (US$75.6 million), with ROE improving to 15.5%, up 265 basis points YoY, and a Return on Tangible Equity (ROTE) nearing 20%, underscoring disciplined execution...

Continue reading

Premier Air Charter Chairman’s Letter to Shareholders: Delivering Growth with Discipline and Operational Excellence

Fleet expansion, operational efficiency, and in-house maintenance strategy support scalable growth. CARLSBAD, Calif., May 07, 2026 (GLOBE NEWSWIRE) — Premier Air Charter Holdings Inc. (OTCID: PREM) (“Premier” or the “Company”), an emerging growth company in the private aviation sector, today shared the following letter from the Company’s Chairman, Vincent Monteparte, to provide shareholders with perspective on the Company’s position, progress, and the opportunities ahead. Dear Shareholders, The private aviation sector continues to evolve, driven by shifting customer expectations, constrained aircraft supply, and an increasing premium on reliability, safety, and service quality. Within this environment, Premier Air Charter Holdings Inc. remains firmly focused on disciplined execution, operational excellence, and delivering a differentiated,...

Continue reading

Innventure to Announce First Quarter 2026 Results on May 14, 2026

ORLANDO, Fla., May 07, 2026 (GLOBE NEWSWIRE) — Innventure, Inc. (NASDAQ: INV) (“Innventure”), an industrial growth conglomerate, today announced it will release its first quarter 2026 financial results after market close on Thursday, May 14, 2026. Management will host a conference call on the day of the release at 5:00 pm ET to discuss the results. The event will be webcasted live via our investor relations website https://ir.innventure.com/ or via this link. A replay of the event webcast will be made available on Innventure’s Investor Relations website following the call. About InnventureInnventure, Inc. (NASDAQ: INV), an industrial growth conglomerate, focuses on building companies with billion-dollar valuations by commercializing breakthrough technology solutions. By systematically creating and operating industrial enterprises...

Continue reading

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments, today provided an update on the expansion of its CompuFlo® medical business, highlighting increasing physician utilization, expanding clinical engagement, and continued development of its commercial and reimbursement infrastructure. Advisor Program Driving Utilization and Real-World Data Generation Since launching the CompuFlo® Advisor Program in February 2026, the Company has onboarded physician advisors and initiated procedural use across key Medicare Administrative Contractor (MAC) jurisdictions, including Novitas, First Coast Service Options, and Palmetto, as well as select commercial payers. The program is currently active in NJ, FL, PA, NY, TN, TX, and GA, with expansion into...

Continue reading

Nightfood Holdings Inc. (OTCQB: NGTF) Strengthening Position in Evolving AI-Driven Robotics Landscape

NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) — Nightfood Holdings Inc. (OTCQB: NGTF) today announces its placement in an editorial published by AINewsWire (“AINW”), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Service Robotics Rise Transforms How Businesses Operate,” please visit: https://ibn.fm/znCAS Demand for service robotics is accelerating worldwide as organizations increasingly adopt automation to manage workforce shortages, rising operating expenses and efficiency challenges. According to the International Federation of Robotics, adoption continues to broaden across industries, with hundreds of...

Continue reading

GoldHaven Upsizes Flow-Through Financing to up to $1.2 Million on Strong Demand to Expand 2026 Drill Program at Magno

VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) — GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) (“GoldHaven” or the “Company”) is pleased to announce that, due to strong investor demand, it has increased the size of its previously announced flow-through non-brokered financing to gross proceeds of up to $1,200,000 (the “Offering”). The additional capital further strengthens the Company’s fully funded 2026 exploration program at its flagship Magno Project in the Cassiar District of British Columbia and is expected to support an expanded drill campaign targeting a large-scale, multi-phase mineral system with significant silver and critical metals exposure. HIGHLIGHTSFinancing Upsized on Demand: Increased to up to $1.2 million, reflecting strong investor demand Drilling Expansion Underway: Program expected...

Continue reading

MARA Announces Launch of Consent Solicitation for the 8.750% Senior Secured Notes due 2032 of Long Ridge Energy LLC

Miami, FL, May 07, 2026 (GLOBE NEWSWIRE) — MARA Holdings, Inc. (NASDAQ: MARA) (“MARA”) today announced that MARA USA Corporation, its wholly owned subsidiary (the “Offeror”), has commenced a consent solicitation (the “Consent Solicitation”) to amend the indenture (the “Indenture”) governing the outstanding notes of Long Ridge Energy LLC (the “Issuer”), as set forth in the table below (the “Notes”). The terms and conditions of the Consent Solicitation are set forth in a consent solicitation statement dated as of May 7, 2026 (as it may be amended and supplemented from time to time, the “Consent Solicitation Statement”).Title of Notes CUSIP Numbers Aggregate Principal Amount Outstanding Consent Fee(1)8.750% Senior Secured Notes due 2032 54288CAA1U5423CAA6 $600,000,000 $2.50(1) For each $1,000 principal amount of the Notes. Amendment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.